Assistant Professor
Versiti Blood Research Institute
Milwaukee, Wisconsin, United States
Joshua Muia, Ph.D., recently joined the Thrombosis and Hemostasis Program as an Associate Investigator at the Versiti Blood Research Institute in Milwaukee, Wisconsin, United States. Before this role, Dr. Muia was an Assistant Professor of Biochemistry at Oklahoma State University Center for Health Sciences/Oklahoma State University College of Osteopathic Medicine, Tulsa, Oklahoma, United States. His research program focuses on the Biochemistry, Vascular Biology, and Pathophysiology of Metalloproteases ADAMTS13 and ADAMTS7, as well as the von Willebrand factor (VWF) protein. His lab also performs translational research on Thrombotic Thrombocytopenic Purpura (TTP), von Willebrand Disease, Sepsis, and Coronary Artery Disease. Dr. Muia’s lab has developed novel ADAMTS13 assays to standardize plasma ADAMTS13 activity in humans and preclinical animal models with unprecedented sensitivity and detection capabilities. Dr. Muia has been an ISTH member since 2013 and previously served on the Inaugural ISTH Early Career Task Force that later became the ISTH Early Career Committee (ECC). He is a member of the ISTH Diversity, Equity and Inclusion (DEI) Committee and on the Editorial Board of the Journal of Thrombosis and Haemostasis (JTH).
PB0309 - ADAMTS13 activity as a novel biomarker in sepsis
Sunday, June 23, 2024
13:45 – 14:45 ICT
Sunday, June 23, 2024
13:45 – 14:45 ICT
Sunday, June 23, 2024
14:45 – 15:00 ICT
OC 58.6 - von Willebrand disease and immune-mediated TTP
Tuesday, June 25, 2024
09:30 – 10:45 ICT